Oral Iron Supplementation on Alternate vs. Consecutive Days for Iron Deficiency Anemia in Pregnancy

Part of paid clinical trials in Springfield, Illinois.

Sponsor
Southern Illinois University
Study ID
NCT06492512
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • Iron-deficiency Anemia (IDA)
  • Pregnancy

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 45 Years
Healthy Volunteers
Not accepted

Interventions

  • daily ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill — DRUG
    ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill daily
  • alternate day ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill — DRUG
    ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill every other day

Study Details

This will be a randomized clinical trial. Enrolled subjects will be randomized (1:1) into two study arms to receive either daily (Group 1) or alternate day (Group 2) supplementation with one oral pill containing ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill.

Key Dates

Start date
May 27, 2025
Status verified
Apr 2026
Primary completion
Jul 1, 2028
Completion
Jul 30, 2029

Study Design

Enrollment
120 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: 1) Daily dose of ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill
    daily (Group 1) supplementation with one oral pill containing ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill
  • Experimental: 2) Alternate daily dose of ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill
    alternate day (Group 2) supplementation with one oral pill containing ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill

Primary Outcome Measure

reversal of iron deficient anemia [ Time Frame: 8 weeks after the baseline visit ± 7 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Southern Illinois University School of MedicineSpringfieldIllinois62702
Amber Fifer, Pharm D
[email protected]
217-545-4541
Yahia Zeino, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Springfield, IL

By research site
Southern Illinois University School of Medicine· Springfield, IL

Related Studies